To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/857 - attachment 2 (PDF)

Found: respiratory tract and lung infections Pneumonia 3 0 Retroviral infections HIV infection 1 0 Sepsis

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/774 - attachment 2 (PDF)

Found: Other infect ions reported included: sepsis, pneumo nia, lower respiratory tract infect ion, meningi

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/937 - attachment 2 (PDF)

Found: Bacterial infections NEC Administration site cellulitis 1 0 Cellulitis 95 0 Citrobacter sepsis

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 9 (PDF)

Found: Ambulance transport Dementia Difficulty walking Home ox ygen Rehabilitation care Psychiatric illness Sepsis

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 8 (PDF)

Found: Ambulance transport Dementia Difficulty walking Home ox ygen Rehabilitation care Psychiatric illness Sepsis

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/945 - attachment 4 (PDF)

Found: contagiosum 1 0 Mumps viral infections Mumps 7 0 Rubeola viral infections Measles 5 0 Sepsis

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/908 - attachment 3 (PDF)

Found: site pruritus 3 Vaccination site rash 3 Serum sickness -like reaction 3 Allergy to vaccine 3 Sepsis

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/945 - attachment 2 (PDF)

Found: 0 Muscle and soft tissue infections Muscle abscess 1 0 Soft tissue infection 1 0 Sepsis

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/945 - attachment 3 (PDF)

Found: Encephalomyelitis rubella 1 0 Rubeola viral infections Measles 8 0 Measles post vaccine 1 0 Sepsis

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 6 (PDF)

Found: CONFIDENTIAL Page 58of 366Difficulty walking Home ox ygen Rehabilitation care Psychiatric illness Sepsis